, , , , ,

Anti-Bevacizumab Antibodies (AY9) (recommended for ADA assay)

Product specifications

A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.

Catalog Number

BEB-Y9

Product Category

Anti-idiotypic Antibodies

Material Category

Anti-idiotypic Antibodies

Storage Tempreture

-20℃

Species

Mouse

Host

Hybridoma

Target of Antibodies

Bevacizumab

Format

Powder

Conjugate

Unconjugated

Product Size & Price

Product size: 100ug

Product price: $300

Add to quote

Shipping condition & fees

All prices are exclusive of duties, taxes, customs & Shipping fees

Shipping & Handling

Our customer service will inform you about the expected delivery time.

Order Details

We are continuously updating our catalog with advanced verified products. please send your request of our latest COA&SDS datasheet

Limitations

Please note: All products are “FOR RESEARCH USE ONLY”. NOT FOR USE IN DIAGNOSTIC PROCEDURES or Human or Veterinary or Food.

Get a quote